[Inhibition of cellular adhesion and invasion in gliomas].
Sasaki
Hikaru
H
Department of Neurosurgery, Kawasaki Municipal Hospital.
Yoshida
Kazunari
K
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology*; D002401:Cathepsin B / Q000502:physiology; D002448:Cell Adhesion / Q000235:genetics*; D002986:Clinical Trials as Topic; D015195:Drug Design; D005109:Extracellular Matrix / Q000737:chemistry; D005910:Glioma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology*; D006801:Humans; D018960:Hyaluronan Receptors / Q000502:physiology; D006820:Hyaluronic Acid / Q000502:physiology; D006877:Hydroxamic Acids / Q000494:pharmacology / Q000627:therapeutic use; D016023:Integrins / Q000037:antagonists & inhibitors* / Q000502:physiology*; D007797:Laminin / Q000502:physiology; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases / Q000502:physiology; D005810:Multigene Family; D009361:Neoplasm Invasiveness; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D012910:Snake Venoms / Q000494:pharmacology / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000502:physiology
D000970:Antineoplastic Agents; D018960:Hyaluronan Receptors; D006877:Hydroxamic Acids; D016023:Integrins; D007797:Laminin; D061965:Matrix Metalloproteinase Inhibitors; D012910:Snake Venoms; C422910:Cilengitide; D006820:Hyaluronic Acid; C100342:marimastat; D014568:Urokinase-Type Plasminogen Activator; D002401:Cathepsin B; D020782:Matrix Metalloproteinases